Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FAM126A | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
mRNA | AK7 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | RHBDD3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | GXYLT1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | RPL5 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | IQGAP1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | SRRM5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | SGMS2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | SHISA4 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
mRNA | BSN | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |